Myriad Genetics Inc (MYGN)

Payables turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cost of revenue	US$ in thousands	252,200	236,200	202,000	197,600	178,200
Payables	US$ in thousands	—	—	—	—	—
Payables turnover		—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue ÷ Payables
= $252,200K ÷ $—K
= —

Based on the provided data, the payables turnover ratio for Myriad Genetics Inc is not available for the years 2020, 2021, 2022, 2023, and 2024. This indicates that specific information about the company's payables turnover, which measures how efficiently a company is managing its accounts payable, is not disclosed or readily accessible in the financial statements for these years. As a result, a detailed analysis of the company's payables turnover performance over this period cannot be conducted.

Peer comparison

Dec 31, 2024

Company name

Symbol

Payables turnover

Myriad Genetics Inc

MYGN

—

IDEXX Laboratories Inc

IDXX

—

Lantheus Holdings Inc